Michael Boxer

The risk of Parkinson's disease in type 1 Gaucher disease

Gilberto Bultron, Katherine Kacena, Daniel S. Pearson et al. · Journal of Inherited Metabolic Disease · 2010 · 215 citations · Full text

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Jeff P. Sharman, Michael Hawkins, Kathryn S. Kolibaba et al. · Blood · 2015 · 181 citations · Full text

Thromboembolic Risk of Postsplenectomy Thrombocytosis

Michael Boxer · Archives of Surgery · 1978 · 165 citations

Retrospective Study, Thrombosis, Thrombopoiesis +10

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients

Tamar H. Taddei, Katherine Kacena, Mei Yang et al. · American Journal of Hematology · 2009 · 155 citations · Full text

Genetics, Genetic Epidemiology, Pathology +19

The lupus anticoagulant

Michael Boxer, Leonard Ellman, Angelina C. A. Carvalho · Arthritis & Rheumatism · 1976 · 143 citations

Immunology, Pathology, Lupus Anticoagulant +20